• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Allergan scores year-end CGRP nod for migraine med Ubrelvy fiercepharma
    December 31, 2019
    The CGRP migraine prevention field already has three meds from Amgen, Eli Lilly and Teva vying for market share, and now Allergan has scored the first approval for an oral CGRP to treat migraines as they happen.
  • FDA Approves New Treatment for Adults with Migraine americanpharmaceuticalreview
    December 24, 2019
    The U.S. Food and Drug Administration (FDA) approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service